BioCryst Pharmaceuticals
BCRX
#4460
Rank
A$2.95 B
Marketcap
$14.24
Share price
2.61%
Change (1 day)
64.79%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -$1.88

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.97. In 2022 the company made an earnings per share (EPS) of -$2.09 a decrease over its 2021 EPS that were of -$1.62.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.88-10.42%
2022-$2.0929.13%
2021-$1.62-4.63%
2020-$1.7010.2%
2019-$1.540%
2018-$1.5425.64%
2017-$1.234%
2016-$1.1827.12%
2015-$0.93-13.24%
2014-$1.0723.64%
2013-$0.87-30.38%
2012-$1.24-37.3%
2011-$1.9865.79%
2010-$1.20117.14%
2009-$0.55-46.15%
2008-$1.02-26.97%
2007-$1.40-40.67%
2006-$2.3648.51%
2005-$1.591%
2004-$1.5738.89%
2003-$1.13-25%
2002-$1.51231.03%
2001-$0.46-56.72%
2000-$1.0591.43%
1999-$0.552.94%
1998-$0.54-55.84%
1997-$1.2111.59%
1996-$1.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.29-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.32 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.93-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$11.32 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.91-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.78 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.51-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$19.01 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.21-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA